Markets:

Overview

News

Currencies

International

Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

6.370 +0.650 (+11.36%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada

June 22, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 21, 2021

During Monday's morning session, 22 companies made new 52-week lows. Key Facts: China Life Insurance Co (NYSE:LFC) was the largest, in terms of market cap, to...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 17, 2021

Before 10 a.m. ET on Thursday, 16 companies hit new 52-week lows. Areas of Interest: Vertex Pharmaceuticals (NASDAQ:VRTX) was the biggest company by market cap to...

Via Benzinga

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗

June 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...

Via Benzinga

Dreary Day ↗

June 14, 2021

Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.

Via Talk Markets

Happy Friday ↗

June 11, 2021

The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer.

Via Talk Markets

AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares

June 10, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗

June 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...

Via Benzinga

New New Deal Worries ↗

May 27, 2021

Nio is up 1.4% today on another round of Meme buying.

Via Talk Markets

The Surprising Move Vir Stock Made After Winning Covid Drug Authorization ↗

May 27, 2021

GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday.

Via Investor's Business Daily

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

60 Biggest Movers From Yesterday ↗

May 27, 2021

Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced...

Via Benzinga

Worldwide Upbeat ↗

May 21, 2021

The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.

Via Talk Markets

Topics Economy

Another Tough Day For Markets ↗

May 17, 2021

The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”

Via Talk Markets

CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results

May 14, 2021

From AbCellera Biologics Inc.

Via Business Wire

Friday Of The Heavy Week ↗

May 14, 2021

There is nothing like a pending weekend to push Wall Street into recuperation and this worked today

Via Talk Markets

Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug ↗

May 14, 2021

AbCellera stock crumbled Friday after the company guided to lower royalties from Covid treatment partner Eli Lilly in the second quarter.

Via Investor's Business Daily

AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript ↗

May 13, 2021

ABCL earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

AbCellera Reports Q1 2021 Business Results

May 13, 2021

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Present Virtually at Berenberg Conference on May 18, 2021

May 11, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy

May 06, 2021

From AbCellera Biologics Inc.

Via Business Wire

Finns and Danes ↗

May 05, 2021

Stock markets are still uncertain whether to rise or fall after the Tuesday debacle.

Via Talk Markets

Merry Month of May ↗

May 04, 2021

Today the unhinged markets of Monday went into normal mode as the rest of the world's markets re-opened.

Via Talk Markets

AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials ↗

May 04, 2021

AbCellera Biologics Inc (NASDAQ: ABCL) has announced that a second antibody from its collaboration with Eli Lilly and Co (NYSE: LLY), LY-CoV1404, ...

Via Benzinga

New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials

May 04, 2021

From AbCellera Biologics Inc.

Via Business Wire

22 Stocks Moving in Monday's Pre-Market Session ↗

May 03, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.